EU offers out of WTO settlement on drug seizure row

Image
Press Trust of India New Delhi
Last Updated : Jan 21 2013 | 6:57 AM IST

The Government today said the EU wants to settle the row over seizure of Indian generic drugs by some European Union members without involving WTO.

"European Union (EU), recognising the strength of India's case, has offered to settle the matter without resorting to the need to go to the WTO dispute panel stage," Commerce and Industry Minister Anand Sharma said in a written reply to Rajya Sabha.

There have been instances of seizures of consignments of generic (off-patent) medicines at some ports in the EU particularly in the Netherlands while they were in transit to "non-European countries" like Africa and Latin America from India.

He said these seizures symbolises TRIPS (Trade Related Intellectual property Aspects) and that their enforcement agencies were targeting the legitimate generic medicines that were against the fundamental principle of freedom of transit under GATT.

They were also against the Doha declaration on TRIPs and public health.

The minister said none of the medicines involved in the seizure had patents either in India or in destination countries.

India had filed a request for consultation with EU and the Netherlands on May 11 under the Dispute Settlement Undertaking of the WTO.

"Two rounds of consultations have taken place," he added.

Some countries in EU had seized Indian drugs alleging that they violated their patent laws.

The Indian side has been maintaining that these are off patent medicines.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 01 2010 | 4:21 PM IST

Next Story